Chinese B2B pharmaceutical trading platform Yaoshibang has completed its $133 million Series D fundraising on Monday.
Tiger Global, H Capital and DCM Ventures all participated.
Proceeds will be used to hire more talent and to improve platform security.
Yaoshibang is a B2B platform which connects pharmaceutical companies, drug stores and clinics. It sells medicines wholesale together with software services so that chemists can track purchases. Launched in 2015, the platform also offers a training programme for pharmacists.
The platform, which serves 200,000 chemists and clinics online, claims that it sells a gross volume of Rmb10 billion $1.4 billion...